2018, Number 2
<< Back Next >>
Rev Hematol Mex 2018; 19 (2)
Indications of blood components transfusion
Gil-García EM
Language: Spanish
References: 29
Page: 83-90
PDF size: 301.78 Kb.
ABSTRACT
Transfusion medicine is a discipline that interacts with all specialties, with a greater
prescription in the onco-hematological patient as a coadjutant or palliative treatment
and is a cornerstone in hemorrhagic shock. The recommendation in prescribing blood
components is to individualize the therapy based on the patient’s clinical status, the
etiology of the blood component deficit and consider alternatives. The recommendations,
indications and special considerations are described in the different transfusion
procedures. Massive transfusion, the success in resuscitation is to avoid the development
of coagulopathy associated with trauma. Transfusion erythrocyte concentrates, the
objective is to guarantee cellular perfusion, and consider alternatives such as transfusion
of autologous blood, iron and erythropoietin. Platelet transfusion, indications are
based on the ASCO 2018 and AABB guidelines. Fresh frozen plasma, its use is based
on the analysis of blood count, bleeding time and coagulation times. Cryoprecipitates,
indicated in the massive transfusion protocol, Von Willebrand disease and deficiency
of the FXIII factor. Irradiated products, the objective are the prevention of graft-versushost
disease. In conclusion, it is important before prescribing a transfusion to establish
the risk-benefit, to individualize the therapy in the clinical context, to identify etiology
and to establish the therapeutic objective. Comply with the regulations and have the
relevant documents in the patient’s clinical file.
REFERENCES
Frazier K, Higgins J, Bugajski, Jones AR, Brown MR. Adverse Reactions to Transfusion of Blood Products and Best Practices for Prevention. Crit Care Nurs Clin North Am 2017;29(3):271-290.
Daffyd T, et al. SHOT Annual Report Web Edition Final bookmarked. 2015:1-190.
Schoettker P, Marcucci CE, CassoG, Heim C. Revisiting transfusion safety and alternatives to transfusion. La Presse Medicale 2016;45(7-8Pt2):331-40.
Quiltenet Mc, Crighton G, Brunskill S, et al. Optimal dose, timing and ratio of blood products in massive transfusion: results from a systematic review. Transfus Med Rev 2018;32(1):6-15.
Mays J, Hess J. Modelling the effects of blood component storage lesions on the quality of haemostatic resuscitation in massive transfusion for trauma. Blood Transfus 2017;15:153-7.
Cantle PM, Cotton BA. Prediction of massive transfusion in trauma. Crit Care Clin 2017 Jan;33(1):71-84.
Cannon J. Hemorrhagic shock. N Engl J Med 2018;378:370- 9.
Hayakawa M. Pathophysiology of trauma-induced coagulopathy: disseminated intravascular coagulation with the fibrinolytic phenotype. J Intensive Care 2017;31:5-14.
Veigas P, Callum J, Sandro Rizoli, Nascimento B, da Luz LT. A systematic review on the rotational thrombelastometry (ROTEM®) values for the diagnosis of coagulopathy, prediction and guidance of blood transfusion and prediction of mortality in trauma patients. Scand J Trauma Resusc Emerg Med 2016;24(1):114.
DaviesL, BrownTJ, Haynes S, Payne K, Elliott RA, McCollum C. Cost effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model. Health Technol Assess 2006;10(44):1-228.
Blood transfusión. 2015 NICE guidelinenice.org.uk/guidance/ ng24.
Franchini M, Marano G, Mengoli C et al. Red blood cell transfusion policy: a critical literature review. Blood Transfus 2017;15:307-17.
Simon GI, Craswell A, Thom O, Fung YL. Outcomes of restrictive versus liberal transfusion strategies in older adults from nine randomised controlled trials: a systematic review and meta-analysis Lancet/Haematology 2017;4(10):465-474.
Roberts DJ. Expanding Access to Transfusion Medicine and improving practice: guidelines, patient blood management, protocols and products. Transfus Med 2017;27(3):15-317.
Carson J, Darrell J. Triulzi, and Ness P. Indications for and adverse effects of red-cell transfusion. N Engl J Med 2017;377(13):1261-1272.
Shander A, Javidroozi M, Lobel G. Patient blood management in the intensive care unit. Transfus Med Rev 2017;31(4):264-271
Pagano D, Milojevic M, Meestersa M, Benedetto U, et al. Guidelines on patient blood management for adult cardiac surgery. Eur J Cardiothorac Surg 2018;53(1):79-111.
Remy K, Hall M, Cholette J, et al. Mechanisms of red blood cell transfusion-related immunomodulation. Transfusion 2018;58(3):804-15.
Delaney M, Wendel S, Bercovitz RS, et al. Transfusion reactions: prevention, diagnosis, and treatment. Lancet 2016;388:2825-2836.
Peters J, Pendry K. Patient blood management: an update of current guidance in clinical practice. Br J Hosp Med (Lond) 2017;78(2):88-95.
Schiffer C, Bohlke K, Delaney M, et al. Platelet transfusion for patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 2018;36(3):283-299.
Etchill E, Myers S, Raval J, Hassoune A, SenGupta A, Neal MD. Platelet transfusion in critical care and surgery: evidence-based review of contemporary practice and future directions. Shock 2017;47(5):537-49.
Kaufman R, Djulbegovic B, Gernsheimer T, et al. Platelet transfusion: A Clinical Practice Guideline From the AABB. Ann Intern Med 2015;162(3):205-13.
Uhl L, Assmann SF, Hazma TH, Harrison RW, Gernsheimer T, Slichter SJ. Laboratory predictors of bleeding and the effect of platelet and RBC transfusions on bleeding outcomes in the PLADO trial. Blood 2017;130(10):1247-58.
Martínez MC. Hemostasia y Trombosis. 2ª ed. México: Editorial Prado, 2008:167-184.
Levy JH, Grottke O, Fries D, Kozek-Langenecker S. Therapeutic plasma transfusion in bleeding patients: A systematic review. Anesth Analg 2017;124(4):1268-1276.
Winearls J, Reade M, Miles H. Targeted coagulation management in severe trauma: the controversies and the evidence. Anesth Analg 2016;123(4):910-24.
Nascimento B, Goodnough LT, Levy JH. Cryoprecipitate therapy. Br J Anaesth 2014;113(6):922-34.
Kopolovic I, Ostro J, Tsubota H, et al. A systematic review of transfusion-associated graft-versus-host disease. Blood 2015;126(3):406-14.
Full text